Byrna Technologies Adds Three Additional Media Influencers Launching in June
ANDOVER, Mass., May 23, 2024 (GLOBE NEWSWIRE) — Byrna Technologies Inc. (“Byrna” or the “Company”) (Nasdaq: BYRN), a personal defense […]
Victory Square Company Announces Access to Tirzepatide and GLP-1 Injections to its Weight Loss Portfolio
VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company […]
Mosaic débute ses travaux d’explorations à la Baie James
MONTRÉAL, 23 mai 2024 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” ou “La Société”) annonce le début de […]
Mosaic Begins Exploration Work at James Bay
MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) — Mosaic Minerals Corporation (CSE: MOC) (“Mosaic” or “The Company”) announces the start of […]
Stellantis to Webcast Investor Day on June 13
Stellantis to Webcast Investor Day on June 13 AMSTERDAM, May 23, 2024 – Stellantis Chief Executive Officer Carlos Tavares, Chief […]
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company […]
NowVertical Group Announces First Quarter 2024 Earnings Release Date and Financial Webinar
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSX-V: NOW) (OTCQB: NOWVF) (“NOW” or the “Company”), a leading […]
Labrador Gold Provides Update on Sale of Kingsway Project
TORONTO, May 23, 2024 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR:2N6) (“LabGold” or the “Company”) is […]
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 23, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: […]
Tourmaline Bio to Present at the Jefferies Global Healthcare Conference
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) — Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative […]
